Catalio Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,923
Closed -$27.9M 47
2025
Q4
$27.9M Sell
25,923
-31,453
-55% -$30.1M 4.92% 5
2025
Q3
$43.8M Buy
57,376
+3,460
+6% +$2.57M 8.09% 1
2025
Q2
$42M Buy
53,916
+30,234
+128% +$23.5M 8.81% 1
2025
Q1
$19.6M Buy
+23,682
New +$19.7M 4.76% 9

Other funds holding LLY

Catalio Capital Management's LLY Position: Q1 2026 in Review

Catalio Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 25,923 shares — an estimated $27.9M sold.

Catalio Capital Management first reported a position in LLY in Q1 2025 and held it in 4 quarters. The position peaked at $43.8M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Catalio Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Catalio Capital Management sold 25,923 Eli Lilly shares in Q1 2026, an estimated $27.9M.
  • Catalio Capital Management first reported a position in Eli Lilly in Q1 2025 and held it in 4 quarters.
  • Catalio Capital Management's Eli Lilly position peaked at $43.8M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Catalio Capital Management's 13F filing for Q1 2026, filed 15 May 2026.